North America New Drug Delivery Systems Market - Size, Outlook, Trends and Forecasts (2018

North America New Drug Delivery Systems Market - Size

Study Period

2018 - 2032

Base Year For Estimation

2025

Forecast Data Period

2026-2032

Historical Data Period

2018-2024

CAGR

7 %

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

New drug delivery system (NDDS) provides a therapeutic amount of drug to the specific site in the body to accomplish promptly and then maintain the desired drug concentration. The drug- delivery system should deliver drug at a rate control by the necessity of the body over a specified term of treatment. The novel drug delivery technologies enable to formulate the novel drug delivery devices by incorporating the drug molecules into new delivery systems, thus providing numerous therapeutic and commercial advantages.

North America New Drug Delivery Systems Market Segments Size & Growth:

North America new drug delivery systems market size is projected to reach approximately $XX billion by the end of 2024 with a CAGR of close to 9.0% from $XX billion in 2017 during the forecast timeline 2018-2024. Key parameters promoting the market growth include Increase in individual therapy, Requirement of controlled release of drugs, Increasing understanding of drug metabolism per individual and so on. However, Competition, Product Recalls, Stringent Regulatory Guidelines, Stability issues are thereby hampering the market growth.

North America New Drug Delivery Systems Market Segments Share:

North America new drug delivery systems market is segmented into the mode of delivery which comprises of Pulmonary Drug Delivery Devices, Oral

North America New Drug Delivery Systems Market - Growth

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

Delivery Devices, Injectable Drug Delivery system and so on. Among the method of delivery, Injectable drug delivery segment dominated the North America New Drug Delivery Systems Market in 2018. By Mode of action, the market is segregated into Slow dissolving salts and complexes, Hydrodynamic pressure controlled system and so on. By Mode of administration, the market is segmented into Electroporation, Inhalation drug delivery system by nebuliser, Iontophoresis and so on. By Geography, US is leading the market in this category with 65 % of the market share in 2018 and is expected to continue the trend during the forecast period. The introduction of new delivery systems to an existing molecule will significantly improve its safety, efficacy and patient compliance. These factors are bound to substantially affect the North American market for new drug delivery systems.

North America New Drug Delivery Systems Market Trends:

Mylan N.V. announced the U.S. launch of Estradiol Vaginal Cream USP, 0.01%, the first generic version of Allergan’s Estrace Cream. Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, which is indicated in the treatment of vulvar and vaginal atrophy.
Kala Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of product candidates using its proprietary mucus-penetrating particle (MPP) technology, announced that the New Drug Application (NDA) for INVELTYSTM (KPI-121 1%), a topical twice-a-day product candidate for the treatment of inflammation and pain in patients who have undergone ocular surgery, has been accepted for review by the United States Food and Drug Administration (FDA).

North America New Drug Delivery Systems Market Research Report:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
The primary market players, such as
Kala Pharmaceuticals
Mylan Laboratories Inc.
Abbott Laboratories
Mersana Therapeutics
Delpor

atrophy. Kala Pharmaceuticals, Inc.,

You can also purchase parts of this report. Do you want to check out a section wise price list

North America New Drug Delivery Systems Market - Porter's Five Force Analysis

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

Credibility and
Transparency

We actively recruit consumers, business professionals, and elusive individuals for our research panels, fostering enduring relationships. Our commitment to transparency is evident in the comprehensive listing of primary and secondary data sources, ensuring unwavering credibility in our reports.

Exhaustive
Coverage

Uncover the full spectrum with Envision Intelligence. Our detailed and extensive geographical coverage, coupled with survey consultation services, spans brand tracking, concept testing, and consumer behaviour analysis. Adapt to your evolving needs with scalable market research services that leave no facet unexplored.

Competitive
Edge

Stay ahead with Envision Intelligence. Our reports provide the latest market updates up to the date of purchase. Recognising the urgency of impactful decisions, we deliver timely analyses on the unprecedented choices made by CXOs during the COVID-19 crisis—providing valuable insights at no extra cost.

Golden
pportunities

Unearth hidden gems with Envision Intelligence. Our analysts and consultants conduct a comprehensive strategic sieve analysis, augmented by AI tools, to identify non-obvious, golden, and emerging opportunities. Evaluate possibilities that set you apart in the market.

Top-notch Reportsd
Guaranteed

Experience unparalleled depth with Envision Intelligence. Over 70% of our research is exclusive, establishing us as the premier source for in-depth and extensive market insights. Elevate your decision-making with reports that go beyond the ordinary.

Post Purchase
Support

Empower your journey with Envision Intelligence. Our commitment extends beyond the purchase. Enjoy post-purchase support for three months, with queries addressed within 24 business hours via telephone or email. We stand by you in your quest for ongoing success.